drugset / Trial / NCT06235125

Safety and Feasibility of Intraoperative Visualization With Cytalux in Children

NCT06235125 ↗

NaSingle-groupOpen-labelDiagnostic

Summary

Pediatric subjects aged 6-17 with biopsy confirmed cancer and imaging findings suspicious for pulmonary metastatic disease scheduled to undergo pulmonary metastasectomy via and open or minimally invasive approach.

Timeline

Start
2024-04-08
Primary completion
2026-08-31
Completion
2026-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject pafolacianine Diagnostic / imaging agent 0.025 mg/kg Intravenous

Indications